In this review, we aim to explore and debate on the prognostic and predictive role of AR and the AR ratio with other hormone receptors, analyzing studies including patients with ductal carcinoma in situ, early and advanced BC, and outlining the recent findings on the association between AR and dysregulated microRNAs in the specific context of BC. This evidence concerns the gene NR4A1 and ductal breast carcinoma in situ.